HOME >> MEDICINE >> NEWS
Daytrana provides significant effectiveness in both boys and girls with ADHD

SAN DIEGO MAY 23, 2007 Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.

"Few clinical studies have examined gender differences in the response to ADHD treatments. Our study documented that DAYTRANA offered a favorable safety profile and was an effective ADHD treatment in both boys and girls," said Robert Findling, M.D., lead investigator and Professor of Psychiatry at Case Western Reserve University and Director of the Division of Adolescent and Child Psychiatry at University Hospitals Case Medical Center. "The study provides a platform to open a dialogue about gender and ADHD."

Approximately 4.4 million U.S. children aged 4 to 17 years -- about 7.8 percent of all school-age children -- have been diagnosed with ADHD at some point in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). Studies estimated that 11.0 percent of boys have been diagnosed with ADHD in contrast to only 4.4 percent of girls. Experts believe that girls with ADHD are underdiagnosed and, therefore, undertreated.

Shire's DAYTRANA is the first and only patch medication approved by the U.S. Food and Drug Administration (FDA) to treat the symptoms of ADHD in children aged 6 to 12 years. DAYTRANA is available in four dosage strengths 10 mg, 15 mg, 20 mg and 30 mg all designed for once-daily use. When worn for the recommended nine hours, efficacy has been demonstrated from the first time point measured (two hours) through the 12-hour time point. Because Daytrana is a patch, physicians may recommend that patients shorten the wear time if shorter duration of effect is desired
'"/>

Contact: Marion E. Glick
212-601-8273
Porter Novelli
23-May-2007


Page: 1 2

Related medicine news :

1. 12-month study demonstrated tolerability and efficacy of Daytrana
2. Sports concussion research using fMRI provides insight for safe return-to-play decisions
3. Fluorescence diffuse optical tomography provides high contrast, 3-D look at breast cancer
4. New book provides unprecedented look at role of religion over a lifetime
5. New edition of medical reference book provides the latest in hematology
6. Lung cancer screening regimen provides opportunity for cure
7. MERLIN TIMI-36 study provides new safety and efficacy data for unique anti-anginal therapy
8. IceSAR campaign provides glimpse of future Sentinel-1 images over ice
9. Darunavir with FUZEON provides HIV patients a better chance to reach undetectable viral load
10. Optical technique provides improved virtual biopsies of internal surfaces
11. Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... August 31, 2020 , ... Smile Brands ... groups in the United States, today announced the grand opening of another affiliated ... , Patients will enjoy convenient hours, a comfortable office, and full-service care at ...
(Date:8/31/2020)... ... 31, 2020 , ... In an effort to give back to the community ... of each hotel room booked with a special new rate code to benefit children ... , effective immediately. Donations will be applied to any room type, any time, ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author Randy Pausch ... than most people would. Rather than become melancholic, however, he put together a final ... one’s dreams. Randy Pausch took a negative situation and turned it into something that ...
(Date:8/28/2020)... Calif. (PRWEB) , ... August 28, 2020 , ... ... cover a one-year subscription to a customized Lighthouse Health & Wellness mobile app ... support of this project. Motorola Solutions Foundation awards grants each year to organizations, ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ziegler, a ... on its investment in Synchronous Health, a tech-enabled behavioral health and well-being solutions ... of human empathy with artificial intelligence (AI) to increase access and quality of ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... August 31, 2020 , ... Welltech1, the first Israeli VC ... invested $400,000 in PopBase, one of two start-ups that beat 152 companies in ... (GWI). , The competition was part of the GWI’s The Wellness Moonshot: ...
(Date:8/28/2020)... SAN ANTONIO (PRWEB) , ... August 28, 2020 ... ... company and operator of primary care medical centers in Florida and San Antonio ... ambassador for its South Texas medical centers. , In this capacity he will ...
(Date:8/27/2020)... ... August 27, 2020 , ... Austin Oral Surgery – ... pleased to announce Dr. David Szalay, DDS, MD, has joined the practice. An accomplished ... the new Pflugerville office, which is scheduled to open this fall. The new office ...
Breaking Medicine Technology:
Cached News: